Evidence map›Paper›PMID 33898042›Full record

ArticleNew microbes and new infections2021

Genome analysis of

I Dandachi, H Anani, L Hadjadj, S Brahimi, J-C Lagier, Z Daoud, J-M Rolain

Open access · goldAbstract read
In one paragraph

Article in New microbes and new infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Characterization of gut microbiota in patients with diabetic kidney disease.Frontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

I DandachiAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
H AnaniAix Marseille Université, IRD, APHM, VITROME, IHU-Méditerranée Infection, Marseille, France.
L HadjadjAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
S BrahimiAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
J-C LagierAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Z DaoudClinical Microbiology and Infection Prevention, Michigan Health Clinics, Central Michigan University, Mount Pleasant, MI, USA.
J-M RolainAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Aix-Marseille Université · FRInstitut de Recherche pour le Développement · FRCentral Michigan University · USMéditerranée Infection Foundation · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteriaculturomicsLachnoclostridiumnew speciestaxonogenomics

Identifiers

PMID33898042
PMCPMC8054182
OpenAlexW3137678891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.